Comorbidities should be factor in prostate biopsy choice, study finds
UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities – the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) ...
Cancer
May 15, 2013 |
not rated yet |
0
Mass prostate cancer screening doesn't reduce deaths: study
There's new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington ...
Cancer
Jan 06, 2012 |
4 / 5 (2) |
6
|
Recommendation against PSA test goes too far: expert
(Medical Xpress) -- A draft recommendation by the U.S. Preventive Services Task Force calling for an end to routine PSA testing for healthy men age 50 and older goes too far, says a prostate cancer expert at the Siteman Cancer ...
Cancer
Oct 12, 2011 |
5 / 5 (1) |
1
|
Using genetic variants to improve PSA testing technique and reduce biopsies
With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine.
Cancer
Apr 24, 2013 |
5 / 5 (1) |
0
Nearly half of all deaths from prostate cancer can be predicted before age 50
Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.
Cancer
Apr 16, 2013 |
5 / 5 (2) |
0
Eating deep-fried food associated with increased risk of prostate cancer, study finds
Regular consumption of deep-fried foods such as French fries, fried chicken and doughnuts is associated with an increased risk of prostate cancer, and the effect appears to be slightly stronger with regard to more aggressive ...
Cancer
Jan 28, 2013 |
5 / 5 (1) |
0
|
Many men with prostate cancer can avoid early surgery
(Medical Xpress) -- New research suggests that many men with prostate cancer do not need immediate treatment, especially if they have low PSA scores or low-risk tumors that are unlikely to grow and spread.
Cancer
Jul 19, 2012 |
not rated yet |
0
|
Change in PSA levels over time can help predict aggressive prostate cancer
Measurements taken over time of prostate specific antigen, the most commonly used screening test for prostate cancer in men, improve the accuracy of aggressive prostate cancer detection when compared to a single measurement ...
Cancer
Jan 15, 2013 |
not rated yet |
0
Digital rectal exam remains important part of prostate screening
(Medical Xpress)—The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to ...
Cancer
Mar 18, 2013 |
not rated yet |
0
|
Personalizing prostate specific antigen testing may improve specificity, reduce biopsies
Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study published in The Journal of Urology reports that correcting PSA levels for th ...
Cancer
Apr 15, 2013 |
not rated yet |
0
Doctors can now detect hard-to-diagnose prostate cancer
Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more ...
Cancer
Aug 09, 2012 |
5 / 5 (1) |
0
Prostate-specific antigen screening: Values and techniques shape decisions
What's most important to a man as he decides whether or not to undergo prostate-specific antigen- PSA- screening for prostate cancer? What does he value most about the screening? And what's the best way to present the information ...
Cancer
Feb 11, 2013 |
not rated yet |
0
American College of Physicians releases new prostate cancer screening guidance statement
Men between the ages of 50 and 69 should discuss the limited benefits and substantial harms of the prostate-specific antigen (PSA) test with their doctor before undergoing screening for prostate cancer, according to new recommendations ...
Cancer
Apr 08, 2013 |
not rated yet |
0
Alternative PSA screening strategies could reduce harm
(HealthDay)—Compared with standard screening, alternative prostate-specific antigen (PSA) screening strategies could maintain good prostate cancer detection rates while reducing overdiagnoses and unnecessary ...
Cancer
Feb 05, 2013 |
not rated yet |
0
Physicians suggest expert recommendations ignore vital issues for patients
In the medical world, where decisions invariably involve risk and uncertainty, two Beth Israel Deaconess Medical Center physicians note that experts generally base their recommendations on the outcome of death, which is "readily ...
Health
Sep 12, 2012 |
not rated yet |
0
